Last reviewed · How we verify
Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer
Phase I part: to determine the recommended dose, and observe the preliminary response and safety profile of the combination of oral lapatinib with vinorelbine in patients with ErbB2 positive metastatic breast cancer. Phase II part: to determine the progression free survival, response rate, and to evaluate the safety profile of the combination of oral lapatinib with vinorelbine in patients with ErbB2 positive metastatic breast cancer. Phase I part has been completed. Phase II part is underway.
Details
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Phase | PHASE1, PHASE2 |
| Status | COMPLETED |
| Enrolment | 46 |
| Start date | Mon Nov 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Jul 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Metastatic Breast Cancer
Interventions
- lapatinib plus oral vinorelbine
Countries
Taiwan